Media Summary: The vaccinology webinar series is an ongoing engagement activity anchored by the KEMRI Wellcome Trust Research Programme ... COPSS-NISS COVID-19 Data Science Webinar Series January 7. 2021 News Story and Speaker Slides: ... In one of our Biostat Program Mini Seminars, Bo Zhang presents two recent methodological developments motivated by ...

Statistical Aspects Of Vaccine Clinical - Detailed Analysis & Overview

The vaccinology webinar series is an ongoing engagement activity anchored by the KEMRI Wellcome Trust Research Programme ... COPSS-NISS COVID-19 Data Science Webinar Series January 7. 2021 News Story and Speaker Slides: ... In one of our Biostat Program Mini Seminars, Bo Zhang presents two recent methodological developments motivated by ... A brief overview of the PrEPvacc trial followed by a detailed presentation of the In this webinar, Calvin O'Brien, Research Statistician at nQuery, has explored Thought Leader: Dr. Alexandra Hanlon is the Director of the Center for Biostatistics and Health Data Science and a Professor of ...

FDA discusses updates to FDA's Study Data Technical Conformance Guide. CBER's Brenda Baldwin describes the preferred ... This is a recording of a webinar held on 07/22/2026. Medicare Part B covers certain Here we work an example of hypothesis testing in

Photo Gallery

Statistical Aspects of Vaccine Clinical Trial Design and Analysis
The Statistics of COVID-19 Vaccine Trials - December 3, 2020
Bo Zhang: Two Statistical Problems in Vaccine Clinical Trials
S3-01 PrEPVacc trial statistical analysis plan
Sample Sizes for Vaccine Trials
Statistical Design of COVID-19 Vaccine Efficacy Trials | Fireside Chat with Dr. Alexandra Hanlon
Statistical analysis of initial COVID-19 vaccine test results
Holly Janes, PhD - COVID Vaccine Efficacy Trial Designs, Open Questions and Statistical Challenges
Calculate VACCINE EFFICACY from RELATIVE RISK
Study Data Submissions: Office of Vaccines Research and Review (OVRR) Data Submission – May 8, 2018
Hepatitis B Vaccines (Clinical)
Hypothesis Testing Example: Salk Vaccine Trial
View Detailed Profile
Statistical Aspects of Vaccine Clinical Trial Design and Analysis

Statistical Aspects of Vaccine Clinical Trial Design and Analysis

The vaccinology webinar series is an ongoing engagement activity anchored by the KEMRI Wellcome Trust Research Programme ...

The Statistics of COVID-19 Vaccine Trials - December 3, 2020

The Statistics of COVID-19 Vaccine Trials - December 3, 2020

COPSS-NISS COVID-19 Data Science Webinar Series January 7. 2021 News Story and Speaker Slides: ...

Bo Zhang: Two Statistical Problems in Vaccine Clinical Trials

Bo Zhang: Two Statistical Problems in Vaccine Clinical Trials

In one of our Biostat Program Mini Seminars, Bo Zhang presents two recent methodological developments motivated by ...

S3-01 PrEPVacc trial statistical analysis plan

S3-01 PrEPVacc trial statistical analysis plan

A brief overview of the PrEPvacc trial followed by a detailed presentation of the

Sample Sizes for Vaccine Trials

Sample Sizes for Vaccine Trials

In this webinar, Calvin O'Brien, Research Statistician at nQuery, has explored

Statistical Design of COVID-19 Vaccine Efficacy Trials | Fireside Chat with Dr. Alexandra Hanlon

Statistical Design of COVID-19 Vaccine Efficacy Trials | Fireside Chat with Dr. Alexandra Hanlon

Thought Leader: Dr. Alexandra Hanlon is the Director of the Center for Biostatistics and Health Data Science and a Professor of ...

Statistical analysis of initial COVID-19 vaccine test results

Statistical analysis of initial COVID-19 vaccine test results

Professor Shai Ben-David analyzes the

Holly Janes, PhD - COVID Vaccine Efficacy Trial Designs, Open Questions and Statistical Challenges

Holly Janes, PhD - COVID Vaccine Efficacy Trial Designs, Open Questions and Statistical Challenges

Holly Janes, PhD is Professor,

Calculate VACCINE EFFICACY from RELATIVE RISK

Calculate VACCINE EFFICACY from RELATIVE RISK

usmlestudents #

Study Data Submissions: Office of Vaccines Research and Review (OVRR) Data Submission – May 8, 2018

Study Data Submissions: Office of Vaccines Research and Review (OVRR) Data Submission – May 8, 2018

FDA discusses updates to FDA's Study Data Technical Conformance Guide. CBER's Brenda Baldwin describes the preferred ...

Hepatitis B Vaccines (Clinical)

Hepatitis B Vaccines (Clinical)

This is a recording of a webinar held on 07/22/2026. Medicare Part B covers certain

Hypothesis Testing Example: Salk Vaccine Trial

Hypothesis Testing Example: Salk Vaccine Trial

Here we work an example of hypothesis testing in

Statistical methods for improving post-licensure vaccine safety surveillance (Jennifer Nelson)

Statistical methods for improving post-licensure vaccine safety surveillance (Jennifer Nelson)

Topic: